Dr. Edward Holland is currently the Director of Cornea Services at Cincinnati Eye Institute and Professor of Ophthalmology at the University of Cincinnati. Prior to this position, Dr. Holland held the Elias Potter Lyon Chair and was Professor of Ophthalmology and Director of the Cornea Service at the University of Minnesota. Dr. Holland formerly served as the past President for the American Society of Cataract and Refractive Surgery, was a Board of Trustee member and Secretariat for the American Academy of Ophthalmology, Chair and Medical Advisory Board member for the Eye Bank Association of America, and past President and current Board Member of the Cornea Society. An internationally recognized expert in corneal surgery with over 250 peer reviewed publications, Dr. Holland is the recipient of the Castroviejo Award from the Cornea Society, the Life Achievement Honor Award from the American Academy of Ophthalmology, the Binkhorst Medal from the American Society of Cataract and Refractive Surgery, and the Paton Society Award from the Eye Bank Association. Dr. Holland received his MD at Loyola-Stritch School of Medicine in Chicago and trained in Ophthalmology at the University of Minnesota. He completed a fellowship in cornea and external disease at the University of Iowa, and then completed a second fellowship in ocular immunology at the National Eye Institute, National Institutes of Health in Bethesda, Maryland. Dr. Holland has made several visits to China to teach corneal transplantation techniques since 1987.
Dr. Zuguo Liu is the distinguished Changjiang Professor of Ophthalmology, the Director of the Eye Institute and Stem Cell Institute at Xiamen University, and the chairman of Key Laboratory of Fujian Province in Ophthalmology and Vision Sciences. Dr. Liu is a world authority in ocular surface disease and serves as council member of the Asia Cornea Society and is a founding member and President of the Asia Dry Eye Society. He serves as the standing committee of the Chinese Ophthalmology Society and Chinese Ophthalmologist Association, the head of Chinese ocular surface and dry eye branch, the vice chairman of Cornea Disease Advisory Board. He is the deputy Editor-in-Chief for the Chinese Journal of Ophthalmology and Chinese Journal of Experimental Ophthalmology, and his research projects have been supported by more than 50 grants leading to more than 400 papers. Dr. Liu graduated from Hengyang Medical College, received his Master’s and doctoral degree from Sun Yat-sen University of Medical Science and postdoctoral training at Bascom Palmer Eye Institute.
Dr. Nguyen is Professor of Ophthalmology focusing on retinal diseases and Director of the Uveitis and Ocular Inflammation Service at the Byers Eye Institute at Stanford University School of Medicine. Dr. Nguyen is a recognized international authority in retinal diseases and uveitis who has served as Principal Investigator in numerous studies sponsored by the National Eye Institute, research foundations, and global drug development programs in the area of retinal disease and uveitis. His early-stage clinical work paved the way for the development of ranibizumab in diabetic macular edema /retinopathy and aflibercept in neovascular age-related macular degeneration; he also demonstrated the utility of interleukin inhibition in the management of uveitis and ocular inflammation. Dr. Nguyen served previously as Chairman and Professor of Ophthalmology and Director of the Truhlsen Eye Institute and Assistant Dean for Translational Research at the University of Nebraska Medical Center, and Associate Professor of Ophthalmology and Director of Medical Education at the Wilmer Eye Institute, Johns Hopkins University. Dr. Nguyen earned his BS and MSc at Yale University, MD at the University of Pennsylvania and completed his internship in internal medicine at the Massachusetts General Hospital, residency in ophthalmology as well as his retina and uveitis fellowships at the Massachusetts Eye and Ear Infirmary, Harvard Medical School, and his ocular immunology fellowship at the Wilmer Eye Institute.
Dr. Xiaodong Sun is Professor of Ophthalmology at Shanghai Jiao Tong University and Vice President of Shanghai General Hospital and Shanghai Eye Research Institute. Dr. Sun is an internationally recognized expert in retinal diseases. Dr. Sun was selected as an expert reviewer for the China National Medical Products Administration (China NMPA) and has been a principal investigator in multiple global clinical studies for retinal disease including LUCENTIS, EYLEA, RTH258, and faricimab. Dr. Sun received his medical retinal training at the Bascom Palmer Eye Institute and Shanghai Medical University.